Stifel Nicolaus Lowers Adient (NYSE:ADNT) Price Target to $26.00
by Renee Jackson · The Cerbat GemAdient (NYSE:ADNT – Get Free Report) had its price target decreased by stock analysts at Stifel Nicolaus from $28.00 to $26.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 31.55% from the stock’s current price.
Other analysts also recently issued research reports about the company. Barclays boosted their price objective on Adient from $26.00 to $29.00 and gave the stock an “equal weight” rating in a report on Monday, May 11th. Weiss Ratings upgraded shares of Adient from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 13th. Citigroup upgraded shares of Adient from a “neutral” rating to a “buy” rating and upped their price target for the company from $30.00 to $33.00 in a research report on Wednesday, April 15th. JPMorgan Chase & Co. lowered their price objective on shares of Adient from $28.00 to $26.00 and set a “neutral” rating on the stock in a research report on Thursday, April 23rd. Finally, UBS Group boosted their target price on shares of Adient from $33.00 to $34.00 and gave the company a “buy” rating in a research note on Thursday, July 9th. Five investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Adient presently has an average rating of “Hold” and an average target price of $28.11.
View Our Latest Research Report on ADNT
Adient Price Performance
NYSE:ADNT traded down $0.03 during trading hours on Monday, reaching $19.76. 67,257 shares of the company’s stock were exchanged, compared to its average volume of 1,033,214. The company has a quick ratio of 0.91, a current ratio of 1.10 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $1.55 billion, a P/E ratio of 27.79, a price-to-earnings-growth ratio of 0.38 and a beta of 1.53. Adient has a 12 month low of $17.68 and a 12 month high of $27.32. The business’s 50-day simple moving average is $20.96 and its two-hundred day simple moving average is $21.55.
Adient (NYSE:ADNT – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.52 EPS for the quarter, beating analysts’ consensus estimates of $0.44 by $0.08. The company had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.62 billion. Adient had a return on equity of 7.28% and a net margin of 0.39%.The company’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.69 EPS. Sell-side analysts expect that Adient will post 2.13 EPS for the current fiscal year.
Insider Activity
In related news, EVP Heather M. Tiltmann sold 22,000 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $22.71, for a total value of $499,620.00. Following the completion of the sale, the executive vice president owned 110,886 shares of the company’s stock, valued at approximately $2,518,221.06. The trade was a 16.56% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.94% of the stock is currently owned by corporate insiders.
Institutional Trading of Adient
Large investors have recently added to or reduced their stakes in the business. Leonteq Securities AG acquired a new position in shares of Adient during the 4th quarter worth $30,000. Quarry LP increased its position in Adient by 163.9% during the third quarter. Quarry LP now owns 2,304 shares of the company’s stock worth $55,000 after buying an additional 1,431 shares during the last quarter. Raymond James Financial Inc. bought a new position in Adient during the second quarter valued at about $63,000. Parallel Advisors LLC boosted its stake in shares of Adient by 19.4% during the 1st quarter. Parallel Advisors LLC now owns 3,186 shares of the company’s stock worth $64,000 after acquiring an additional 517 shares in the last quarter. Finally, Los Angeles Capital Management LLC bought a new position in shares of Adient in the 4th quarter valued at approximately $64,000. 92.44% of the stock is owned by institutional investors.
Adient Company Profile
Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.
Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.
Further Reading
- Five stocks we like better than Adient
- 3 Nuclear Stocks for Investors Willing to Wait Out the Dip
- 3 Medical Device Stocks Giving Investors a Different Healthcare Play
- Cybersecurity Stocks Are Holding Up as the AI Trade Starts to Crack
- Bank Earnings Are Roaring, But Wall Street Isn’t Ready to Celebrate